cancer

Execs behind Imbruvica raise $75M for a new cancer project
Fierce Biotech
Wed, 09/30/15 - 10:44 am
Imbruvica
Corbus Pharmaceuticals
cancer
Rexahn's Human Data Confirms Anti-Cancer Advantage
Yahoo
Wed, 09/30/15 - 09:41 am
Rexahn
RX-3117
Supinoxin
cancer
Sorrento launches another joint venture with a $170M cancer deal
Fierce Biotech
Mon, 09/28/15 - 11:54 am
Sorrento Therapeutics
R&D
cancer
antibodies
Pfizer says it could be leader in cancer with many new drugs
Yahoo/AP
Wed, 09/23/15 - 07:47 am
Pfizer
cancer
immuno-oncology
Amgen, Xencor In $1.75 Billion Cancer Drug Alliance
Investors.com
Wed, 09/16/15 - 09:38 am
Amgen
Xencor
cancer
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Bloomberg
Tue, 09/8/15 - 08:22 am
Roche
Pharma CEOs
UK
cancer
Avastin
Severin Schwan
Not just cancer: Seattle biotechs, researchers explore immunotherapy for other diseases
Bizjournals.com
Fri, 08/28/15 - 07:59 am
Seattle
cancer
immunotherapy
Juno Therapeutics
Google Reveals Gigantic Ambitions To Fight Cancer, Diabetes, Parkinson's, Heart Problems
Forbes
Mon, 08/24/15 - 05:16 pm
Google
Alphabet
diabetes
Parkinson's Disease
cancer
heart disease
From Cancer To Ebola, NewLink Genetics Seeks Vaccines
Investors.com
Sat, 08/22/15 - 08:54 am
vaccines
NewLink Genetics
ebola virus
cancer
ovarian cancer
How Bioinformatics Could Find The Next Breakthrough Cancer Drug
Forbes
Wed, 08/12/15 - 10:51 am
bioinformatics
cancer
cancer immunotherapy
Once Disparaged, 'Me-Too' Drugs Crucial For Lower Costs Of Cholesterol, Hepatitis C And Cancer Drugs
Forbes
Tue, 08/11/15 - 09:56 am
me-too drugs
drug pricing
hepatitis C
cancer
Sprint licenses tumor metabolism program to Bayer in €190M deal
Fierce Biotech
Wed, 07/29/15 - 09:53 pm
Sprint Bioscience
Bayer
R&D
cancer
Biotech Clovis Oncology raising $275 million for new cancer drugs
Bizjournals.com
Wed, 07/8/15 - 09:48 am
Clovis Oncology
rucaparib
cancer
3 Experimental Cancer Drugs Investors Should Be Closely Watching
Motley Fool
Fri, 07/3/15 - 11:20 am
cancer
JCAR015
Juno Therapeutics
Celgene
Celldex Therapeutics
Rentiga
Geron
imetelstat
Novartis playing catch-up in cancer? Not us, says top oncology exec
Fierce Pharma Marketing
Wed, 06/24/15 - 08:35 am
Novartis
oncology
cancer
immuno-oncology
Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A
Bloomberg
Wed, 06/24/15 - 08:29 am
Juno Therapeutics
Kite Pharma
M&A
cancer
CAR-T
Doctors propose tool to help gauge the value of cancer drugs
Yahoo/AP
Tue, 06/23/15 - 10:36 am
physicians
cancer
Hot Atara snags licensing deal with leading cancer center
Bizjournals.com
Mon, 06/15/15 - 09:54 am
Atara
cancer
Memorial Sloan Kettering
AstraZeneca R&D executive Morrison to lead cancer firm Syndax
Yahoo/Reuters
Mon, 06/15/15 - 09:28 am
AstraZeneca
R&D
cancer
Briggs Morrison
Syndax
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Fierce Biotech
Tue, 06/9/15 - 12:00 pm
Celegene
Lycera
M&A
cancer
T-cells

Pages